PAVmed stockholders re-elect Sparks and Baxter as Class A directors; approve ESPP amendment

PAVmed Inc.

Re-elected Ronald M. Sparks with 3,810,460 votes for (67,490 withheld) and Timothy Baxter with 3,815,060 for (62,890 withheld).
Approved ESPP amendment increasing shares from 15,774 to 215,774 and raising annual evergreen limit from 5,556 to 500,000.
Ratified CBIZ CPAs P.C. as independent auditor for FY 2026 (4,306,623 for, 25,814 against, 2,554 abstain).
Approximately 59.6% of outstanding shares were represented at the June 24, 2026 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.